Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false answering member label
creator	label
publisher	pref label
tabling member	label

Search

830233

	human indexable
	published
	registered interest
	answer date	29/01/2018
	date	24/01/2018
	date tabled	24/01/2018
	ddp created	24/01/2018 22:00:50
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	26/01/2018 14:05:23 01/02/2018 14:13:08
	hansard heading	NHS: Drugs
	house id	1
	identifier	124894
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	01/02/2018 13:41:13
	question text	To ask the Secretary of State for Exiting the European Union, with reference to the speech made by the Secretary of State for International Trade to the American Enterprise Institute of 24 July 2017, what assessment the Government has made of the effect of the increase in non-tariff barriers to trade between 2010 and 2015 on the UK pharmaceutical industry after the UK leaves the EU.
	session	2017/19
	session number	1
	tabling member constituency	Eddisbury
	tabling member printed	Antoinette Sandbach
	title	House of Commons Tabled Parliamentary Question 2017/19 124894
	type	WrittenParliamentaryQuestion
	uin	124894
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 4091 label Biography information for Mr Robin Walker
	creator	4506 label Biography information for Antoinette Sandbach
	publisher	25259 pref label House of Commons
	tabling member	4506 label Biography information for Antoinette Sandbach

946902

	human indexable
	published
	registered interest
	answer date	04/09/2018
	date	23/07/2018
	date tabled	23/07/2018
	ddp created	23/07/2018 21:53:13
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	23/07/2018 22:05:52 14/09/2018 10:32:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	167159
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	14/09/2018 10:01:10
	question text	To ask the Secretary of State for Exiting the European Union, what steps he has taken in negotiations on the UK leaving the EU to promote mutual access to medicines and drugs.
	session	2017/19
	session number	1
	tabling member constituency	Belfast North
	tabling member printed	Nigel Dodds
	title	House of Commons Tabled Parliamentary Question 2017/19 167159
	type	WrittenParliamentaryQuestion
	uin	167159
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 4091 label Biography information for Mr Robin Walker
	creator	1388 label Biography information for Lord Dodds of Duncairn
	publisher	25259 pref label House of Commons
	tabling member	1388 label Biography information for Lord Dodds of Duncairn

540147

	human indexable
	published
	registered interest
	answer date	21/07/2016
	date	19/07/2016
	date tabled	19/07/2016
	ddp created	19/07/2016 20:32:57
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	19/07/2016 20:39:29 28/07/2016 12:57:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	43441
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	28/07/2016 12:25:09
	question text	To ask the Secretary of State for Exiting the European Union, what his policy is on future UK involvement in the Innovative Medicines Initiative.
	session	2016/17
	session number	2
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	title	House of Commons Tabled Parliamentary Question 2016/17 43441
	type	WrittenParliamentaryQuestion
	uin	43441
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member 373 label Biography information for Sir David Davis
	creator	1533 label Biography information for Dame Diana Johnson
	publisher	25259 pref label House of Commons
	tabling member	1533 label Biography information for Dame Diana Johnson